PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction Post date 4 May 2022 ← Variation in treatment and outcomes of patients in hospital with acute myocardial infarction → Hepatitis: Ukrainian refugees should be offered vaccines and free treatment, says WHO